Nemiroff Alex

General Counsel Nemiroff sells 25,130 shares at avg $193.09 for $4.9M, reducing stake by 54.7%, stock now -15.5% from 52-week high.

Nemiroff Alex, General Counsel and Secretary, executed 4 separate sales totaling 25,130 shares for $4,852,255.51 on 2025-11-20, disposing of 54.7% of his pre-transaction holdings and retaining 20,831 shares. The blended average transaction price was $193.09, while the current price stands at $169.80, representing a 12.0% decline from his sale price and placing the stock 15.5% below its 52-week high. The company is unprofitable with net income of $-73,934,000.00 over its most recent full fiscal year and zero quarterly revenue, though it posted 249.5% annual revenue growth. His prior trade at PRAX (a November 2024 sell) was followed by a 90-day gain of 6.5%, indicating his historical sales at this ticker have not been well-timed. This large divestiture occurs as the stock pulls back significantly from recent highs, warranting examination of whether his timing reflects operational or valuation concerns.

General Counsel & Secretary sells 8,239 shares of PRAX at $80.20; stock now trading at $71.76, -15.4% from 52-week high.

Nemiroff Alex, General Counsel and Secretary, sold 8,239 shares at $80.20 on 2024-11-14 for $660,827.46, reducing holdings by 44.4% from 18,540 shares to 10,300 shares. The sale occurred near the upper end of the 52-week range ($13.05–$84.83), with the stock currently trading at $71.76, representing a -15.4% decline from the 52-week high. The company is unprofitable, with most recent quarter revenue of $302,000.00 against net income of $-51,910,000.00, and full-year results also showed negative net income. This large proportional reduction in a key officer's position—coupled with the sale at peak valuations and the company's persistent losses—merits investor scrutiny of near-term operational developments and cash runway.